-
TAE Life Sciences and Stella Pharma Announce Strategic Agreement for Development and Commercialization of BPA for BNCT Cancer Therapy in the USA and Europe | Morningstar
ソース: Buzz FX / 13 11 2024 19:50:29 America/Chicago
TAE Life Sciences and Stella Pharma Announce Strategic Agreement for Development and Commercialization of BPA for BNCT Cancer Therapy in the USA and Europe TAE Life Sciences and Stella Pharma Announce Strategic Agreement for Development and
Read more...